Jacobson TA - Search Results

1

National Lipid Association Annual Summary of Clinical Lipidology 2016.

Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA. Bays HE, et al. Among authors: jacobson ta. J Clin Lipidol. 2016 Jan-Feb;10(1 Suppl):S1-43. doi: 10.1016/j.jacl.2015.08.002. J Clin Lipidol. 2016. PMID: 26891998 Review.

2

Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart disease.

Jacobson TA. Jacobson TA. Curr Opin Lipidol. 1997 Dec;8(6):369-74. doi: 10.1097/00041433-199712000-00008. Curr Opin Lipidol. 1997. PMID: 9412778 Review.

3

Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.

Jacobson TA, Griffiths GG, Varas C, Gause D, Sung JC, Ballantyne CM. Jacobson TA, et al. Arch Intern Med. 2000 May 8;160(9):1361-9. doi: 10.1001/archinte.160.9.1361. Arch Intern Med. 2000. PMID: 10809042

4

Characteristics of US adults with the metabolic syndrome and therapeutic implications.

Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JC, Gause D, Varas C, Ballantyne CM. Jacobson TA, et al. Diabetes Obes Metab. 2004 Sep;6(5):353-62. doi: 10.1111/j.1462-8902.2004.00354.x. Diabetes Obes Metab. 2004. PMID: 15287928

5

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Davidson MH, et al. Among authors: jacobson ta. J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005. J Clin Lipidol. 2011. PMID: 21981835

6

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.

Jacobson TA, Glickstein SB, Rowe JD, Soni PN. Jacobson TA, et al. J Clin Lipidol. 2012 Jan-Feb;6(1):5-18. doi: 10.1016/j.jacl.2011.10.018. Epub 2011 Nov 3. J Clin Lipidol. 2012. PMID: 22264569 Review.

7

Achieving adherence to lipid-lowering regimens.

Brown WV, Jacobson TA, Braun LT. Brown WV, et al. Among authors: jacobson ta. J Clin Lipidol. 2013 Jan-Feb;7(1):4-13. doi: 10.1016/j.jacl.2012.11.004. Epub 2012 Dec 21. J Clin Lipidol. 2013. PMID: 23351577 No abstract available.

8

Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting.

Simpson RJ Jr, Tunceli K, Ramey DR, Neff DR, Kern DM, Hsieh HM, Wertz DA, Stephenson JJ, Marrett E, Tomassini JE, Jacobson TA. Simpson RJ Jr, et al. Among authors: jacobson ta. J Clin Lipidol. 2013 Sep-Oct;7(5):399-407. doi: 10.1016/j.jacl.2013.06.002. Epub 2013 Jun 18. J Clin Lipidol. 2013. PMID: 24079280

9

An assessment by the Statin Intolerance Panel: 2014 update.

Guyton JR, Bays HE, Grundy SM, Jacobson TA, The National Lipid Association Statin Intolerance Panel. Guyton JR, et al. Among authors: jacobson ta. J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S72-81. doi: 10.1016/j.jacl.2014.03.002. J Clin Lipidol. 2014. PMID: 24793444

10

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV. Jacobson TA, et al. J Clin Lipidol. 2014 Sep-Oct;8(5):473-88. doi: 10.1016/j.jacl.2014.07.007. Epub 2014 Jul 15. J Clin Lipidol. 2014. PMID: 25234560 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page